ArticleScientific reports2024

Gynecologic Cancer InterGroup CA125 response has a high negative predictive value for CHK1 inhibitor RECIST response in recurrent ovarian cancer.

Kristen R Ibanez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.